“clinical-trials” Archives

in
Entry Author Date Location
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
In Cholesterol Drug Price Fight, Real Message Is “Wait Til Next Year” 08/18/16 National
Cerulean’s Shares Routed as Cancer Drug Comes up Short Again 08/17/16 Boston
OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again 08/16/16 Seattle
Aldeyra Surges on New Data, Another Step For Inflammation Drug 08/09/16 Boston
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Metis Foundation, Targeting Military Researchers, Plans Fund Raise 08/05/16 Texas
Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer 08/05/16 Boston
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble 07/26/16 Boston
Tobira Fails Main Goal in NASH Study, But Forges Ahead To Next Trial 07/25/16 San Francisco
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting 07/19/16 Boston
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact 06/29/16 Boston
More Job Cuts at Infinity As AbbVie Sends Back Blood Cancer Drug 06/28/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week 06/27/16 Boston
As Macchiarini Faces Charges, Biostage Forges Ahead With New Tech 06/23/16 Boston
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short 06/14/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
In Race to Relief, Amgen Touts New But Incomplete Migraine Data 06/09/16 San Francisco
Pivoting Again, Catabasis Looks to NASH After Cholesterol Drug Flops 06/07/16 Boston
Page 1 of 18 next page »